tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CPRX Stock Latest News

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
Press ReleasesCatalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
1M ago
CPRX
Catalyst Pharmaceuticals price target raised to $30 from $26 at H.C. Wainwright
PremiumThe Fly
Catalyst Pharmaceuticals price target raised to $30 from $26 at H.C. Wainwright
1M ago
CPRX
Catalyst Pharmaceuticals price target raised to $30 from $25 at Truist
PremiumThe Fly
Catalyst Pharmaceuticals price target raised to $30 from $25 at Truist
1M ago
CPRX
Catalyst Pharmaceuticals price target raised to $31 from $27 at Citi
PremiumThe Fly
Catalyst Pharmaceuticals price target raised to $31 from $27 at Citi
1M ago
CPRX
Catalyst Pharmaceuticals backs FY24 revenue view $455M-$475M,
PremiumThe Fly
Catalyst Pharmaceuticals backs FY24 revenue view $455M-$475M,
1M ago
CPRX
Catalyst Pharmaceuticals reports Q2 EPS 33c, consensus 26c
PremiumThe FlyCatalyst Pharmaceuticals reports Q2 EPS 33c, consensus 26c
1M ago
CPRX
Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
1M ago
CPRX
Catalyst Pharmaceutical Partners (CPRX) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Catalyst Pharmaceutical Partners (CPRX) Q2 Earnings Cheat Sheet
2M ago
CPRX
Catalyst Pharmaceuticals enters exclusive agreement with Kye Pharmaceuticals
PremiumThe Fly
Catalyst Pharmaceuticals enters exclusive agreement with Kye Pharmaceuticals
2M ago
CPRX
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
PremiumPress Releases
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
2M ago
CPRX
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
PremiumPress Releases
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
2M ago
CPRX
Catalyst Pharmaceuticals (NASDAQ:CPRX): A Growth-Oriented Value Investment Opportunity
PremiumMarket News
Catalyst Pharmaceuticals (NASDAQ:CPRX): A Growth-Oriented Value Investment Opportunity
3M ago
CPRX
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
PremiumPress ReleasesCatalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
4M ago
CPRX
Catalyst receives FDA approval for increased maximum daily dose for FIRDAPSE
Premium
The Fly
Catalyst receives FDA approval for increased maximum daily dose for FIRDAPSE
4M ago
CPRX
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
Premium
Press Releases
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
4M ago
CPRX
Catalyst Pharmaceuticals price target raised to $26 from $24 at H.C. Wainwright
PremiumThe Fly
Catalyst Pharmaceuticals price target raised to $26 from $24 at H.C. Wainwright
4M ago
CPRX
Catalyst Pharmaceutical’s Buyback: A Double-Edged Sword for Financial Health and R&D Investment?
PremiumCompany Announcements
Catalyst Pharmaceutical’s Buyback: A Double-Edged Sword for Financial Health and R&D Investment?
4M ago
CPRX
Catalyst Pharmaceuticals reports Q1 EPS 19c, consensus 17c
PremiumThe Fly
Catalyst Pharmaceuticals reports Q1 EPS 19c, consensus 17c
4M ago
CPRX
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
4M ago
CPRX
Catalyst Pharmaceutical Partners (CPRX) Q1 Earnings Cheat Sheet
PremiumPre-EarningsCatalyst Pharmaceutical Partners (CPRX) Q1 Earnings Cheat Sheet
5M ago
CPRX
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
Premium
Press Releases
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
5M ago
CPRX
Catalyst Pharmaceuticals announces support for inaugural LEMS awareness day
Premium
The Fly
Catalyst Pharmaceuticals announces support for inaugural LEMS awareness day
6M ago
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >